Background/Objectives: Non-alcoholic fatty liver disease (NAFLD) is considered an integral part of metabolic syndrome (MS). We aimed to explore the inter-relations of MS and dietary composition in subjects with and without hepatic steatosis and to identify the nutritional risk factors contributing to NAFLD. Subjects/Methods: In all 98 subjects with steatosis and 102 controls were selected for the study after screening 260 consecutive healthy individuals. Anthropometric and nutritional information, biochemical data and clinical profile were analyzed. Prevalence of MS was determined based on the consensus statement for diagnosis of MS for Asian Indians. Multiple logistic regression analysis was done to predict the dietary risk factors in NAFLD. Results: Prevalence of MS was 44.9% among NAFLD cases and 25.5% among controls (P ¼ 0.003). Subjects with NAFLD had significantly higher values of body mass index (BMI), waist circumference (WC), percent body fat, total cholesterol, triglycerides and blood pressure than controls. The total calorie intake, percent of carbohydrate and fat intake of NAFLD cases was significantly higher than controls. Multiple logistic regression analysis showed BMI (odds ratio 6.03 (95% confidence interval 3.26-11.14)), WC (5.49 (2.59-11.57)) and percent dietary fat intake (2.51 (1.99-3.31)) as independent nutritional risk factors in NAFLD. Conclusions: In this study, there is a high prevalence of MS among subjects with steatosis and metabolic disorders were closely related to NAFLD. BMI, WC and percent fat intake are independent dietary risk factors in NAFLD. Decreased nutritional intake with restricted fat may constitute an important therapy in subjects with NAFLD.
Introduction
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming a public health problem worldwide and is recognized as one of the most common forms of liver diseases (Clark et al., 2003; Kang et al., 2006) with an estimated prevalence of 10-24 percent in the general population (Angulo, 2002; Collantes et al., 2004; Bajaj et al., 2009) . NAFLD encompasses a spectrum of liver disorders characterized by macrovesicular hepatic fat accumulation alone (steatosis) or accompanied by signs of hepatocyte injury, mixed inflammatory cell infiltrate and variable hepatic fibrosis (non-alcoholic steatohepatitis) (Chitturi and Farrell, 2001; Sanyal, 2002; Farrell, 2003; Farrell and Larter, 2006; Chitturi et al., 2007; Farrell et al., 2007) .
NAFLD was initially believed to be a benign condition, however recent studies have shown it to be an integral part of metabolic disorders, such as central or overall obesity, type II diabetes, hypertension, dyslipidemia or metabolic syndrome (MS) (Marchesini et al., 2003; Fan et al., 2005) . NAFLD is considered to be the hepatic manifestation of MS with insulin resistance as a central pathogenic factor. MS is increasing globally with a prevalence of 24 to 44 percent in US population (Ford et al., 2002) . Several studies in India indicated the prevalence of MS ranging from 11 to 41 percent (Misra and Vikram, 2002; Vikram et al., 2006) depending on the region and urbanization. MS can be induced by different environmental factors, including dietary habits (Eckel et al., 2005) and reports have shown that the adverse cardiovascular risk profile seen as part of MS is associated with a diet high in carbohydrate, low in unsaturated fat and decreased physical activity (Thompson et al., 2003; Arora and McFarlane, 2005) . A recent study showed that patients with NAFLD consuming a diet high in carbohydrates have greater odds of hepatic inflammation (Kang et al., 2006) suggesting a link between diet and liver injury. It has also been reported that there is an early development of steatohepatitis in obese, hypercholesterolemic, diabetic foz/foz mice fed on high-fat diet for 12 months (Larter et al., 2009) . However, the inter-relations of NAFLD, MS, dietary composition and physical activity have been sparsely studied in asymptomatic healthy individuals. Based on the available literature, we hypothesized that subjects with hepatic steatosis would be consuming more calories as carbohydrates and fats contributing to obesity and greater degree of MS. To test this hypothesis, we studied anthropometric, dietary and metabolic profiles in asymptomatic subjects with and without hepatic steatosis. Using this data, we aimed to predict the dietary risk factors in NAFLD.
Materials and methods
All individuals coming to the Asian Institute of Gastroenterology, Hyderabad, India, for routine health check as part of their employment scheme from April 2008 to December 2008, who consented to participate in the study, were enrolled.
A total of 260 apparently healthy asymptomatic subjects were randomly enrolled, out of which 60 were excluded based on the following reasons:
1. Patients of cardiovascular diseases and chronic illnesses (renal or hepatic failures and tuberculosis). 2. Elevated aminotransferase levels (41.5 times above normal). 3. Individuals on lipid lowering medications. 4. Positive hepatitis B, C antibodies and human immunodeficiency virus antibody. 5. Alcohol use of more than 20 g per week within the past 3 months or history of alcohol abuse. 6. History of use of medications reported to cause steatosis (steroids, valproic acid, methotrexate, tetracycline and tomoxifen). 7. Use of weight loss medications or participation in weight loss programs. 8. Presence of gall stones and fibrosing steatohepatitis in the ultrasound and acoustic radiation force imaging sonoelastography.
The protocol was approved by the Institutional Review Board and all subjects signed the consent form at the time of screening for the study.
Laboratory parameters
Clinical information regarding the medical history and medications was recorded for all participants. Laboratory parameters to exclude other causes of chronic liver diseases were examined. Biochemical testing for metabolic abnormalities including fasting triglyceride, high-density lipoprotein-cholesterol, total cholesterol and fasting glucose was carried out.
MS. MS was defined based on the consensus statement for diagnosis of obesity, abdominal obesity and MS for Asian Indians (Misra et al., 2009) as subjects who have three or more of the following:
1. Central obesity measured by WC greater than 80 cm in women and 90 cm in men. 2. Blood pressure greater than or equal to 130/85 mm Hg. 3. Fasting glucose greater than or equal to 100 mg/dl. 4. Fasting triglyceride greater than or equal to 150 mg/dl. 5. High-density lipoprotein-cholesterol less than 50 mg/dl in women and 40 mg/dl in men.
Ultrasound imaging
Abdominal ultrasound and acoustic radiation force imaging sonoelastography (Fierbinteanu-Braticevici et al., 2009) was carried out for all subjects by the radiologist who was blinded to the clinical and laboratory characteristics of the participants. Acoustic radiation force imaging sonoelastography has been proved to be a non-invasive imaging method for staging liver fibrosis. Subjects with liver fibrosis as revealed by acoustic radiation force imaging were excluded from the study and only those with steatosis were included.
Nutritional assessment Anthropometric assessment. Anthropometric measurements included height, body weight, percent body fat, waist and hip circumferences. Height was measured to the nearest centimeter by using a standardized height scale. Body weight was measured using an electronic weighing scale to the nearest kilogram. Percent body fat was estimated using bioelectric impedance analysis (Omron Health Care Co. Ltd, Japan). Waist and hip circumferences were measured by placing a measuring tape horizontally around the waist (narrowest part of torso) and hip (greatest part of buttocks). Body mass index (BMI) was calculated by using the formula weight (kg)/height (m)
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. BMI in all the participants was classified as follows (Misra et al., 2009) (Carroll et al., 1996) was used to collect nutrient and dietary information on the food groups and miscellaneous food items. The questionnaire included the followings:
1. Foods consumed during the day. 2. Food items consumed weekly or monthly. 3. Alcohol intake. 4. Types and amounts of oils and visible fats used.
Daily intake of nutrients and foods were estimated by summing up all the raw foods consumed on a daily, weekly and monthly basis. Nutrient calculation (calories, percentage of carbohydrates, proteins and fats) from raw foods was done using standard nutritive values of Indian foods (Gopalan et al., 2004) .
The type and duration of physical activity undertaken by the participants was assessed by guidelines provided by Center of Disease Control (CDC, 1996) and physical activity was defined as light, moderately vigorous and combination activities. Light activity (5 kcal/min) included walking, gardening, carpentry, bowling, biking and dancing. Moderately vigorous activity (10 kcal/min) included swimming, tennis, squash, jogging, running and basketball. Combined activity (7.5 kcal/min) included weight lifting.
Statistical analysis
Data were analyzed by Statistical Package for Social Science (SPSS 13.0, SPSS South Asia Pvt. Ltd, Bangalore, India). Data were presented as mean and standard deviation. The differences between cases and controls were tested for normally distributed continuous data using the Student's test.
The differences between cases and controls were tested for non-normal continuous data using Wilcoxon rank sum test.
The difference between proportions was tested using w 2 -test. A bivariate analysis followed by multiple logistic regression was carried out to identify the independent predictors of hepatic steatosis and to estimate odds ratio and 95% confidence interval. P-value o0.05 was considered as statistically significant.
Results
Complete clinical profile, nutritional information, ultrasonography data and biochemical analysis were done for 200 subjects. Among these, 98 subjects who were diagnosed to have hepatic steatosis were classified as cases whereas 102 subjects who had normal ultrasonography were taken as controls. Among the cases, only eight subjects had elevated transaminases, yet none had values corresponding to the definition of non-alcoholic steatohepatitis as elevation of liver enzymes by 1.5-5 times. There was no significant difference in the mean age, sex and socio-economic status of cases and controls. Liver biopsy was not a part of our protocol as it is not practical to do an invasive test in a healthy asymptomatic population limiting our study to be an ultrasonography based study.
Comparison of anthropometric data, laboratory parameters, nutrient composition and physical activity patterns of cases with controls Cases had significantly higher BMI, body fat percentage and waist circumference (WC) compared with the controls (Table 1 ). The BMI was o18 kg/m 2 in 14.7% (n 15) of controls and 45% (n 46) had a high BMI of X25 kg/m 2 . However, a majority of cases (75.5%) had a high BMI, indicating overweight and obesity categories. Mean total cholesterol, high-density lipoprotein-cholesterol and triglyceride were significantly higher in cases than in controls (P ¼ 0.001, 0.001, 0.034 respectively), as shown in Table 1 . MS was more prevalent in cases as compared with controls (44.9 vs 25.5%, P ¼ o0.01). Impaired fasting glucose was present in 10 (10.2%) cases and seven (6.8%) controls. Three cases (3%) and none of the controls had diabetes.
The total calorie intake, percent carbohydrate and fat intake were significantly higher in cases than in controls. The mean total calories consumed per day by cases and controls were 8100 ± 1205 and 6890 ± 1255 kJ, respectively (P ¼ o0.0001) ( Table 2 ). Only 46% (n ¼ 92) of the total participants were involved in physical activity. The average physical activity was 720 kcal/week (3014 kJ/week) with no significant difference seen between cases and controls (P ¼ 0.36).
On multiple logistic regression analysis, odds ratio (95% confidence interval) for BMI, WC and percent fat intake were 6.03 (3.26-11.14), 5.49 (2.59-11.51 ) and 2.51 (1.99-3.31), respectively. These variables were detected to be independent predictors of hepatic steatosis (Table 3) .
Discussion
The present study compares the nutritional and metabolic profiles of healthy subjects with and without hepatic steatosis. We confirmed the prevalence of MS in NAFLD subjects (B44%) to be significantly higher than that of the general population (Dixon et al., 2001; Bajaj et al., 2009; Uchil et al., 2009) . Further, the nutritional risk factors in hepatic steatosis were evaluated to suggest the diet modifications required for asymptomatic healthy subjects with NAFLD. It was been recently reported that the prevalence of genetic variants in apolipoprotein C3 were associated with NAFLD and insulin resistance in a cohort study of Asian and non-Asian Indians, suggesting that other factors are responsible for the increased prevalence of NAFLD in Asian Indians (Peterson et al., 2006 (Peterson et al., , 2010 .
Despite the increasing prevalence of NAFLD among Asian Indians, there are no studies with robust evidence on the nutritional predictors of hepatic steatosis. Three independent, modifiable nutritional risk factors in hepatic steatosis were observed in our study: BMI, WC and percent fat intake. Though Kang et al. showed that high carbohydrate-low fat consumption is strongly associated with greater histological severity of NAFLD, the carbohydrate intake was not shown to be an independent predictor of hepatic steatosis in our study, which may be attributed to the condition of simple steatosis of our subjects. Furthermore, the Indian diet that is predominantly vegetarian, is rich in complex carbohydrates, moderate in proteins and high in visible cooking fat and with emerging urbanization and increasing affluence, the usage of fats in India has markedly increased (Sudha et al., 2004) . Therefore, the increased fat intake could be a contributing factor for central adiposity and hepatic steatosis. It has also been shown that a high-fat diet in genetically predisposed obese and diabetic mice caused earlier onset of steatohepatitis and rapid transformation of simple steatosis to fibrosing steatohepatitis (Larter et al., 2009) . This observation suggests that diet therapy, particularly control of fat content in meals, should be recommended in NAFLD subjects. Overall, the results of the present study predict the nutritional risk factors of hepatic steatosis to be BMI, WC and percent fat intake. Decreased diet intake with restricted fat may constitute an important therapy in subjects with hepatic steatosis. Risk factors in non-alcoholic fatty liver disease E Sathiaraj et al
